Press Releases

DENVER, Oct. 10, 2019 /PRNewswire/ -- Radiology Imaging Associates, PC will welcome 20 physicians from Rocky Mountain Radiologists, PC to the RIA practice on January 1, 2020. "The two practices are naturally compatible," said Andrew Fisher, MD, MBA, member of the RIA Board of Directors, and director of

DUBLIN, Oct. 10, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global pharmaceutical company with more than 70 years of heritage in eye care, today announced a national education campaign called My Glaucoma. The campaign is designed to help people understand the burden of living with glaucoma and empower those with the disease and their caregivers to f

DUBLIN, Oct. 10, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global pharmaceutical company with more than 70 years of heritage in eye care, today announced a national education campaign called My Glaucoma. The campaign is designed to help people understand the burden of living with glaucoma and empower those with the disease and their caregivers to f

BOSTON, Oct. 10, 2019 /PRNewswire/ -- Increasing prevalence of chronic disease, rapidly aging populations, and huge middle-class growth in developing economies are combining to push the growth in global healthcare expenditure from 2.4% in 2015 to an estimated 7.5% by 2020, making next year's growth alone an additional $750 billion. For many

VENICE, Fla., Oct. 10, 2019 /PRNewswire/ -- Tuscan Gardens® of Venetia Bay has partnered with Seattle-based Eld

CARLSBAD, Calif., Oct. 10, 2019 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), the leader in RNA-targeted therapeutics, announced today that its scientists will present data highlighting advances in the company's antisense technology that have the potential to address an unprecedented range of diseases at the 15th Annual Meeting of the Oligo

DAVIS, Calif., Oct. 10, 2019 /PRNewswire/ -- EicOsis LLC, a pharmaceutical startup developing a new class of oral non-narcotic analgesics, announced today that the U.S. Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) application to initiate Phase 1 clinical trials for their drug candidate, EC5026, for the treatment of pain.

SANTA CLARA, Calif., Oct. 10, 2019 /PRNewswire/ -- Glassbeam, Inc., the premier machine data analytics company, announced today that it has expanded its strategic reseller relationship with Agiliti Imaging ("Agiliti"), a division of Agiliti, Inc., more than doubling its current installed base in the Southern California region. Glassbeam

REDWOOD CITY, Calif., Oct. 10, 2019 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced that the Company will release its financial results for the third quarter ended September 30, 2019 after the market closes on

SAN FRANCISCO, Oct. 10, 2019 /PRNewswire/ -- Lawsuit Settlement News reports that over 13,000 plaintiffs have filed suit against Monsanto (a subsidiary of Bayer) due to alleged toxic exposure to the manufacturer's Roundup brand weed killer. Plaintiffs claim their non-Hodgkin lymphoma was directly caused by exposure to the glyphosate-based product. Four plaintiffs